STXS Stereotaxis Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: STXS

Price (delayed)

$1.32

Market cap

$132.27M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.24

Enterprise value

$126.95M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 19

Stereotaxis is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information ...

Highlights
The EPS has grown by 17% YoY
STXS's gross margin is up by 11% YoY and by 3.2% QoQ
STXS's quick ratio has soared by 65% YoY but it is down by 13% QoQ
The net income has grown by 4.4% YoY but it has contracted by 3% from the previous quarter
STXS's equity is down by 15% since the previous quarter
STXS's revenue is down by 5% YoY and by 3.6% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.stereotaxis.com
Peers: BSX EW ATRC JNJ

Key stats

What are the main financial stats of STXS

STXS stock price

How has the Stereotaxis stock price performed over time
Intraday
-5.71%
1 week
0%
1 month
-7.04%
1 year
-54.95%
YTD
-42.61%
QTD
-23.26%

Financial performance

How have Stereotaxis's revenue and profit performed over time
Revenue
$30.07M
Gross profit
$16.71M
Operating income
-$22.76M
Net income
-$22.32M
Gross margin
55.6%
Net margin
-74.2%
STXS's gross margin is up by 11% YoY and by 3.2% QoQ
Stereotaxis's net margin has decreased by 7% from the previous quarter
STXS's operating margin is down by 7% from the previous quarter
STXS's revenue is down by 5% YoY and by 3.6% from the previous quarter

Price vs fundamentals

How does STXS's price correlate with its fundamentals

Growth

What is Stereotaxis's growth rate over time

Valuation

What is Stereotaxis stock price valuation
P/E
N/A
P/B
10.54
P/S
4.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.22
The EPS has grown by 17% YoY
STXS's P/B is 49% below its last 4 quarters average of 21.8 and 47% below its 5-year quarterly average of 20.9
STXS's equity is down by 15% since the previous quarter
The stock's price to sales (P/S) is 32% less than its last 4 quarters average of 6.9 and 31% less than its 5-year quarterly average of 6.8
STXS's revenue is down by 5% YoY and by 3.6% from the previous quarter

Efficiency

How efficient is Stereotaxis business performance
Stereotaxis's return on equity has surged by 56% YoY and by 21% QoQ
STXS's return on invested capital is up by 30% year-on-year and by 8% since the previous quarter
Stereotaxis's ROA has increased by 15% YoY and by 4.4% from the previous quarter
The ROS has contracted by 7% from the previous quarter

Dividends

What is STXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STXS.

Financial health

How did Stereotaxis financials performed over time
The company's total assets is 46% higher than its total liabilities
STXS's quick ratio has soared by 65% YoY but it is down by 13% QoQ
The company's total assets rose by 35% YoY and by 2.9% QoQ
Stereotaxis's debt is 58% less than its equity
STXS's debt to equity has dropped by 89% year-on-year but it is up by 14% since the previous quarter
STXS's equity is down by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.